The use of antibodies in the prophylaxis and treatment of infections.

about

Using convalescent whole blood or plasma as passive immune therapy for the global war against Ebola.Swift antibodies to counter emerging viruses.The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.

P2860

Q34762871-97DD6551-4E8C-41E9-96C3-DF243820EB3E Q35989719-D4D779DF-7AA8-4390-9089-D6167E057482 Q47555346-0BCDCAEA-1539-4150-9505-EF59F29043AC

P2860

The use of antibodies in the prophylaxis and treatment of infections.

Item

http://www.wikidata.org/entity/Q36779708

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The use of antibodies in the prophylaxis and treatment of infections.

@ast

The use of antibodies in the prophylaxis and treatment of infections.

@en

type

Item

label

The use of antibodies in the prophylaxis and treatment of infections.

@ast

The use of antibodies in the prophylaxis and treatment of infections.

@en

prefLabel

The use of antibodies in the prophylaxis and treatment of infections.

@ast

The use of antibodies in the prophylaxis and treatment of infections.

@en

P1476

The use of antibodies in the prophylaxis and treatment of infections.

@en

P2093

Peter J Lachmann

http://www.w3.org/2001/XMLSchema#string

P2860

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Continuous cultures of fused cells secreting antibody of predefined specificity

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Naturally occurring antibodies devoid of light chains

Cross-reacting antibodies enhance dengue virus infection in humans

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

P304

e11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMI.2012.2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260177952

http://www.w3.org/2001/XMLSchema#string

P698

26038423

http://www.w3.org/2001/XMLSchema#string

P932

3630915

http://www.w3.org/2001/XMLSchema#string

The use of antibodies in the prophylaxis and treatment of infections.

about

P2860

P2860

The use of antibodies in the prophylaxis and treatment of infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932